| Literature DB >> 35875616 |
Shahad Saif Khandker1,2, Morshed Alam1, Forhad Uddin1, Ummay Mahfuza Shapla3, Nafisa Lubna1, Tanusree Amy Mazumder4, Mahfuza Marzan5, Milon Mondal6, Md Ibrahim Khalil1, Nurul Karim1, Md Salman Shakil7, Md Sakib Hossen8.
Abstract
Alternanthera philoxeroides, a tropical herb and edible vegetable, has been popular as a medicinal plant. Applying in vitro approach, we initially attempted to assess the phytochemicals, bioactive chemicals, as well as antioxidant and anticoagulant activities of this plant. Following that, the in vivo toxicological effects of methanolic extracts of A. philoxeroides using different doses on the kidney, heart, lung, liver, stomach, brain, and blood of female Swiss Albino mice were investigated. We estimated phytochemicals content as well as antioxidant activity through DPPH, NO, CUPRAC, and reducing power assays, followed by the anticoagulant activities of PT and aPTT and bioactive compounds using HPLC. To confirm the biocompatibility of A. philoxeroides extracts, histopathological and hematological parameters were examined in a mice model. Total phenol, flavonoid, and tannin content in A. philoxeroides was 181.75 ± 2.47 mg/g, 101.5 ± 3 .53 mg/g, and 68.58 ± 0.80 mg/g, respectively. Furthermore, the HPLC study confirmed the presence of four phenolic compounds: catechin, tannic acid, gallic acid, and vanillic acid. The methanolic extract of A. philoxeroides showed considerable antioxidant activity in all four antioxidant assay methods when compared to the standard. In comparison to ascorbic acid, A. philoxeroides also demonstrated a minor concentration-dependent ferric and cupric reduction activity. In vivo evaluation indicated that A. philoxeroides extracts (doses: 250, 500, and 1000 mg/kg) had no negative effects on the relative organ or body weight, or hematological indicators. Our study concluded that A. philoxeroides had significant antioxidant and anticoagulant activities and demonstrated no negative effects on the body or relative organ weight, histopathological, and hematological indices in the mouse model.Entities:
Year: 2022 PMID: 35875616 PMCID: PMC9300360 DOI: 10.1155/2022/8152820
Source DB: PubMed Journal: J Toxicol ISSN: 1687-8191
Figure 1Distinguishing features of Alternanthera philoxeroides.
Total phenols, flavonoids, and tannin contents in A. philoxeroides.
| Phytochemicals | Quantity present in |
|---|---|
| Total phenols (GAEs) | 181.75 ± 2.47 |
| Total flavonoids (CEs) | 101.5 ± 3.53 |
| Total tannins (TEs) | 68.58 ± 0.80 |
Data are presented as means ± SD (standard deviation). GAE, gallic acid equivalent; CE, catechin equivalent; and TE, tannic acid equivalent.
Phenolic acids identified in Alternanthera philoxeroides.
| Standard | Retention time of standards (min) | Retention time of | Concentration (mg/g) |
|---|---|---|---|
| Tannic acid | 3.781 | 3.533 | 0.248 |
| Gallic acid | 4.297 | 3.963 | 0.334 |
| Catechin | 5.202 | 5.111 | 0.091 |
| Vanillic acid | 5.998 | 5.720 | 0.278 |
| Rutin | 6.599 | ND | ND |
| Quercetin | 7.533 | ND | ND |
Here, ND = not detected.
Figure 2This figure shows (a) DPPH free radical scavenging activity, (b) NO free radical scavenging activity, (c) reducing power capacity, and (d) cupric reducing antioxidant capacity of the methanolic extract of A. philoxeroides.
Anticoagulant activities of A. philoxeroides extract (PT and aPTT).
| Anticoagulant test | Control clotting time | Clotting time in the presence of | ||
|---|---|---|---|---|
| 250 | 500 | 1000 | ||
| PT | 9.53 | 10.16 | 10.68 | 13.26 |
| aPTT | 55.92 | 56.94 | 60.82 | 66.28 |
Here, the values are expressed in time (sec.).
Anticoagulant activity of the bioactive chemicals derived from A. philoxeroides
| Bioactive chemicals | Control PT | PT values of bioactive chemicals (10 | Control aPTT | aPTT values of bioactive chemicals (10 |
|---|---|---|---|---|
| Tannic acid | 9.53 | 12.62 | 55.92 | 57.54 |
| Gallic acid | 13.33 | 56.26 | ||
| Catechin | 11.71 | 56.87 | ||
| Vanillic acid | 15.91 | 56.14 |
Here, the values are expressed in time (sec.).
Figure 3Effect of the methanol extract of A. philoxeroides on (a) body weight and (b) relative organ weight. Data are presented as the mean ± standard deviation (n = 6). No significant difference was calculated for tests in the A. philoxeroides methanol extract (250 mg/kg, 500 mg/kg, and 1000 mg/kg) treated groups compared to control were compared with the control group (p < 0.05) using one-way ANOVA followed by Dunnett's multiple comparison. Here, ns= nonsignificant.
Figure 4Histological images of heart, liver, kidney, lung, stomach, and brain tissue of A. philoxeroides (500 mg/kg and 1000 mg/kg) treated and controlled mice. Sections of the heart, liver, kidney, lung, stomach, and brain tissue were harvested from the female Swiss Albino mice 28 days of A. philoxeroides (500 mg/kg to1000 mg/kg) after treatment. Test samples were processed with hematoxylin and eosin (H and E) stain. Images were taken at 20X magnification. No pathological changes were observed in the case compared to the control.
Influence of three dosages of A. philoxeroides methanol extract on the blood parameters of mice.
| Hematological parameters | Groups | ||||
|---|---|---|---|---|---|
| Control |
|
|
| ||
| Erythrocyte count | RBC (m/uL) | 2.52 ± 0.90 | 5.70 ± 2.95 | 3.61 ± 0.25 | 3.73 ± 1.80 |
| HGB (g/dL) | 13.15 ± 0.05 | 12.95 ± 0.25 | 13.50 ± 0.20 | 12.35 ± 0.55 | |
| HCT/PCV (%) | 10.45 ± 3.85 | 24.95 ± 13.05 | 15.60 ± 1.00 | 16.35 ± 7.95 | |
| MCV (fL) | 41.30 ± 0.60 | 43.65 ± 0.35 | 43.25 ± 0.25 | 43.70 ± 0.20 | |
| MCH (pg) | 59.95 ± 21.55 | 31.35 ± 16.65 | 37.55 ± 2.05 | 42.20 ± 18.90 | |
| RDW (%) | 19.90 ± 0.90 | 16.70 ± 3.80 | 21.65 ± 0.05 | 17.80 ± 0.80 | |
|
| |||||
| Leukocyte count | WBC | 7600 ± 1100 | 4750 ± 2350 | 3050 ± 1550 | 4750 ± 2850 |
| Lymphocyte (%) | 67.00 ± 1.00 | 92.00 ± 4.00 | 81.00 ± 7.00 | 86.00 ± 5.00 | |
| Monocyte (%) | 1 ± 1 | 1.5 ± 0.5 | 0 ± 0 | 0 ± 0 | |
| Neutrophil (%) | 23.50 ± 1.50 | 6.00 ± 4.00 | 4.50 ± 2.50 | 8.00 ± 2.00 | |
| Basophil (%) | 0 ± 0 | 0 ± 0 | 0.5 ± 0.5 | 1 ± 0 | |
| Total cir. eosinophil Count (TEC) (/cumm) | 847 ± 197 | 24 ± 0 | 365 ± 95 | 57 ± 0 | |
|
| |||||
| Platelet count | Total platelet count (PC) (/cumm) | 2309500 ± 225500 | 1298000 ± 563000 | 1787500 ± 176500 | 1622000 ± 307000 |
| MPV (m^3) | 11.10 ± 0.10 | 9.40 ± 0.70 | 10.80 ± 0.20 | 9.80 ± 0.70 | |
| PDW (%) | 28.75 ± 3.45 | 30.7 ± 7.1 | 24.85 ± 3.55 | 23.8 ± 8 | |
| PCT (%) | 2.56 ± 0.23 | 1.26 ± 0.62 | 1.93 ± 0.23 | 1.57 ± 0.19 | |
The results are presented as the mean ± SD of six animals in each group. The mean values with different superscript () on the same row denote significance differences compared to the control (p < 0.05). This dataset was analyzed using a one-way ANOVA followed by Dunnett's multiple comparisons.